Adapting To Changing China Regulations Propels Sanofi But How Far?
Executive Summary
Just months ago, China's category two vaccines sector barely showed signs of life after being hit hard by a quality scandal. It now helps Sanofi deliver double-digit growth, showing what difference adapting to regulatory change can make in China.